Lund, Sweden, March 1st, 2016
For release 14.00 CET, 08:00 a.m. EST, March 1st, 2016
TFS appoints Dr. Montserrat Barceló Riera as Chief Operating Officer.
TFS International (TFS) is pleased to announce the appointment of Dr. Montserrat Barceló as Chief Operating Officer (COO). This new appointment will further strengthen the TFS global organization with Dr. Barceló assuming leadership of the company’s two Business Areas, TFS DEVELOP™ and TFS PEOPLE™, responsible for delivering global, full-service clinical trial solutions and functional resourcing services, respectively. The two Business Areas employ more than 750 professionals in over 25 company locations worldwide.
Dr. Barceló is an industry veteran with more than 20 years of clinical development experience who joined TFS in 2005 following the acquisition of Clinical Data Care (CDC). She has held various senior management positions at TFS, most recently as European Executive Vice President, and has worked closely with all business areas and service functions within the company. In her new role as COO, Dr. Barceló will report to the Chief Executive Officer, Mr. Daniel Spasic.
Dr. Barceló received her medical degree from the University of Barcelona in Spain and also holds a degree in Business Administration and a Master's in Pharmaceutical Industry Medicine.
“I am very pleased with this appointment and look forward to continue working with Montse. Her successful track record with TFS and her contributions have led the TFS European business to significant growth over the last years. Montse exemplifies the TFS company values. She possesses a profound understanding of our business, a shared vision of the strategic roadmap, and a commitment to excellence,” says Mr. Daniel Spasic, CEO.
Located at the TFS US regional Boston office, Mr. Daniel Spasic, CEO, will intensify his work with the Board of Directors to deliver on the strategic growth initiatives, technology enhancements and complementary acquisitions.